Alfred P. West, Jr. Executive Chairman | Last year we celebrated SEI’s 55th anniversary—a milestone marked by the It has been an honor to help lead our great company through more than a half-century of SEI’s values set a strong foundation from which we nurture our culture, develop and align our talent to strategic opportunities, and build meaningful connections with our clients, communities, and the industry. Our strategy to cultivate innovation includes initiatives and programs that test new ideas, so we can deliver enhanced and new solutions that meet tomorrow’s demands for constant evolution. Just as we’re dedicated to our clients’ success, our employees are passionate about making a positive impact on our communities. Giving back through acts of Today, we stand well-positioned to drive an even greater impact. With our |
Table of contents | ||||||||||||||||||||
How to vote Your vote is important Vote by 11:59 p.m. ET on May 28, 2024 for shares held directly and by 11:59 p.m. ET on May 24, 2024 for shares held in a Plan. Refer to the Internet Go to www.proxyvote.com and follow the Telephone If your shares are held in Mail Complete, sign, date, and return the Voting at the Annual Meeting This year’s Annual Meeting will be Please read both this Proxy Statement and our Annual Report before you cast your vote. They are available free of | ||||||||||||||||||||
Powering the | ||||||||||||||||||||
Approval of adoption of 2024 Omnibus Equity Compensation Plan | ||||||||||||||||||||
Proposal 4 | ||||||||||||||||||||
Our values. | |||||||||||
Courage | Integrity | ||||||||||
Collaboration | Inclusion | ||||||||||
Connection | Fun | ||||||||||
Non-Hispanic or Latino | |||||||||||||||||||||||||||||||||||||||||||||||
Job categories | Hispanic or Latino | Male | Female | Overall totals | |||||||||||||||||||||||||||||||||||||||||||
White | Black or African American | Native Hawaiian or Pacific islander | Asian | American Indian or Alaskan Native | Two or more races | White | Black or African American | Native Hawaiian or Pacific islander | Asian | American Indian or Alaskan Native | Two or more races | ||||||||||||||||||||||||||||||||||||
Male | Female | ||||||||||||||||||||||||||||||||||||||||||||||
Exec/Sr. Officials & Mgrs | 0 | 0 | 20 | 0 | 0 | 2 | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 26 | ||||||||||||||||||||||||||||||||
First/Mid Officials & Mgrs | 9 | 5 | 398 | 10 | 0 | 40 | 1 | 2 | 218 | 13 | 0 | 17 | 0 | 3 | 716 | ||||||||||||||||||||||||||||||||
Professionals | 74 | 35 | 1674 | 104 | 2 | 289 | 2 | 38 | 727 | 60 | 0 | 191 | 1 | 11 | 3208 | ||||||||||||||||||||||||||||||||
Technicians | 0 | 0 | 7 | 0 | 0 | 2 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 12 | ||||||||||||||||||||||||||||||||
Sales Workers | 2 | 0 | 131 | 2 | 0 | 3 | 0 | 2 | 30 | 2 | 0 | 4 | 0 | 0 | 176 | ||||||||||||||||||||||||||||||||
Administrative Support | 1 | 1 | 3 | 0 | 0 | 2 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 12 | ||||||||||||||||||||||||||||||||
Craft Workers | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | ||||||||||||||||||||||||||||||||
Operatives | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
Laborers & Helpers | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
Service Workers | 1 | 0 | 16 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 20 | ||||||||||||||||||||||||||||||||
Total | 87 | 41 | 2254 | 116 | 2 | 338 | 3 | 46 | 985 | 75 | 0 | 213 | 1 | 15 | 4176 | ||||||||||||||||||||||||||||||||
Previous Report Total | 77 | 36 | 2150 | 111 | 2 | 293 | 2 | 35 | 984 | 68 | 0 | 193 | 1 | 11 | 3521 |
Proxy summary. Annual Meeting of Shareholders DATE AND TIME Wednesday, May 29, 2024 at 9 a.m. ET LOCATION www.virtualshareholdermeeting.com/SEIC2024 RECORD DATE March 22, 2024 | ||||||||||||||
Voting matters Shareholders will be asked to vote on the following matters at the Annual Meeting. We encourage you to read the entire Proxy Statement before voting. | ||||||||||||||
PROPOSAL | BOARD RECOMMENDATION | PAGE | ||||||||||||
1 | To elect three directors for a term expiring at our 2027 Annual Meeting of Shareholders Our Board unanimously recommends that Shareholders vote FOR the election of Mr. Carl A. Guarino, Ms. Stephanie D. Miller and Mr. Carmen V. Romeo to the class of directors whose term will expire at our 2027 Annual Meeting of Shareholders. | Vote FOR each director nominee | ||||||||||||
2 | To approve on an advisory basis the compensation of our named executive officers Our Board seeks a non-binding advisory vote from our Shareholders to approve the compensation of the named executive officers as disclosed in this Proxy Statement. Our Board and our Compensation Committee value the opinions of our Shareholders. To the extent that there is any significant vote against the compensation of our named executive officers, we will consider our Shareholders’ concerns, and the Compensation Committee will evaluate whether any actions are necessary to address those concerns. | Vote FOR | ||||||||||||
3 | To approve the adoption of the 2024 Omnibus Equity Compensation Plan Our Board unanimously recommends a vote for approval of our 2024 Omnibus Equity Compensation Plan. | Vote FOR | ||||||||||||
4 | To ratify the appointment of KPMG LLP as independent registered public accountants to examine our consolidated financial statements for 2024 The Audit Committee of our Board has selected KPMG LLP (“KPMG”) as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2024. The Audit Committee and the Board seek to have the Shareholders ratify the appointment of KPMG by the Audit Committee. | Vote FOR |
Carl A. Guarino | |||||
Chief Executive Officer Mr. Qualifications Mr. Guarino has great familiarity with the Company and its market units, particularly the investment advisor segment, and his experience knowledge of the information technology industry provide the Board with a valuable perspective on the Company’s business activities. |
Stephanie D. Miller | |||||
Chief Executive Officer of Hazeltree / Age: 55 / Director since: October 2023 Ms. Miller is Chief Executive Officer at Hazeltree, a leading provider of treasury and liquidity management solutions for the asset management industry. She previously served as Chief Administrative Officer at Gilded, a Miami-based gold trading fintech. Prior to Gilded, she was CEO at Intertrust Group, a public Dutch Euronext company, where she led the digital transformation of the client experience and development of a robust organic and inorganic growth strategy. Miller also held executive roles at SS&C Technologies, JP Morgan, and Citco Fund Services. Qualifications With more than 25 years’ experience across financial services, she has a combination of experience in traditional financial markets, digital assets, and emerging markets. |
Carmen V. Romeo | |||||
Private Investor / Age: 80 / Director since: June 1979 From December 1985 to December 2004, Mr. Romeo served as an Executive Vice President of the Company. Mr. Romeo was our Treasurer and Chief Financial Officer from June 1979 until September 1996. Mr. Romeo officially retired from the Company effective December 31, 2004. Mr. Romeo was a certified public accountant with Arthur Andersen & Co. prior to 1979. Qualifications In addition to his familiarity with public company accounting and financial management issues, Mr. Romeo has great familiarity with the Company, and particular knowledge of the Company’s business and related technology and asset management solutions, from his previous role with the Company as the person having managerial responsibility for the Company’s Investment Advisors business. |
Jonathan A. Brassington | |||||
Executive Vice President & DCX Business Line Leader, Capgemini, Inc. / Age: 49 Director since: April 2022 Qualifications Mr. Brassington has deep expertise in the use of digital technologies to transform the wealth management sector gained from his experience providing strategic advisory and technology transformation services to many asset and wealth management firms, including five of the seven largest global asset managers. He has also advised venture and private equity firms on new and existing fintech investments, giving him insight into the opportunities and challenges faced by SEI’s investment and wealth management business, as well as the |
William M. Doran | |||||
Consultant; Retired Partner Morgan Lewis & Bockius LLP (Law Firm) / Age: 83 Director since: March 1985 From October 1976 to October 2003, Mr. Doran was a partner in the law firm of Morgan, Lewis & Bockius LLP, Philadelphia, PA, a firm that provides significant legal services to SEI, our Mr. Doran is a trustee of SEI Tax Exempt Trust, SEI Daily Income Trust, SEI Institutional Managed Trust, SEI Institutional International Trust, SEI Asset Allocation Trust, SEI Institutional Investments Trust, SEI Catholic Values Trust, New Covenant Funds, Adviser Managed Trust, The Advisors’ Inner Circle Fund III, Gallery Trust, Schroder Series Trust and Schroder Global Series Trust, each of which Qualifications Mr. Doran’s legal training and |
Alfred P. West, Jr. | |||||
Executive Chairman, SEI / Age: 81 / Director since: 1968 Qualifications Mr. West has been the Executive Chairman of our Board since June 2022. Prior to June 2022, Mr. West served as our Chief Executive Officer since our inception in |
Ryan P. Hicke | |||||
Chief Executive Officer, SEI / Age: 46 / Director since: June 2022 Mr. Hicke is our Chief Executive Officer, responsible for the global business strategy and execution for the Company across our three pillars of expertise: investments, operations, and technology. Mr. Hicke’s 24-year career at SEI includes 11 years in asset management and 13 years in technology across various parts of our business, with his tenure evenly split between U.S. and global experience. Prior to being named CEO, he was our Chief Information Officer overseeing the information technology strategy and investment operations for the Company. Mr. Hicke also previously served as head of our Technology Unit, as well as a Managing Director in our U.K. wealth management business. Mr. Hicke holds a degree in Finance from Saint Joseph’s University. He also serves on the board of directors for the Philadelphia Alliance for Capital and Technologies. Qualifications Mr. Hicke’s history and experience across the Company expose him to the needs and challenges of our clients on a daily basis, while sitting on our Executive team for many years has given him insight into strategically managing and running the Company. |
Kathryn M. McCarthy | |||||
Independent Consultant and Financial Advisor / Age: 75 Director since: October 1998 Ms. McCarthy is an independent consultant and financial advisor to global families and family offices. She is a director and a member of the Audit Committee Ms. McCarthy was the President of Qualifications Ms. McCarthy’s experience as a consultant and financial advisor to |
Committee | |||||||||||||||||
Name | Term | Audit | Compensation | Nominating and | Legal and Regulatory | ||||||||||||
Carl A. Guarino (1) | Nominee, expiring 2027 | Member | Chair | Chair | |||||||||||||
Stephanie D. Miller (1) | Nominee, expiring 2027 | Member | Member | ||||||||||||||
Carmen V. Romeo (1) | Nominee, expiring 2027 | Chair | Member | Member | |||||||||||||
Jonathan A. Brassington (1) | Expiring 2025 | Member | Member | Member | |||||||||||||
William M. Doran | Expiring 2025 | Chair | |||||||||||||||
Alfred P. West, Jr. | Expiring 2025 | ||||||||||||||||
Ryan P. Hicke | Expiring 2026 | ||||||||||||||||
Kathryn M. McCarthy (1) (2) | Expiring 2026 | Member | Member | Member | |||||||||||||
(1) Independent Director (2) Lead Independent Director | |||||||||||||||||
Name of Individual or Identity of Group | Number of Shares Owned (1) | Percentage of Class (2) | ||
Alfred P. West, Jr. (3) | 21,099,250 | 13.0 | ||
William M. Doran (4) | 9,743,752 | 6.0 | ||
Carmen V. Romeo (5) | 3,044,344 | 1.9 | ||
Kathryn M. McCarthy | 112,700 | * | ||
Sarah W. Blumenstein | 45,224 | * | ||
Carl A. Guarino (6) | 34,346 | * | ||
Dennis J. McGonigle | 818,498 | * | ||
Kevin P. Barr | 309,472 | * | ||
Stephen G. Meyer | 327,752 | * | ||
Wayne M. Withrow | 246,859 | * | ||
All executive officers and directors as a group (16 persons) (7) | 37,019,598 | 17.1 | ||
BlackRock, Inc. (8) | 11,154,009 | 6.9 | ||
The Vanguard Group (9) | 11,222,092 | 6.9 | ||
Loomis Sayles & Co., L.P. (10) | 11,793,496 | 7.3 |
Board diversity matrix (as of April 20, 2023 and March 31, 2024) | |||||||||||||||||||||||
Board Size: | |||||||||||||||||||||||
Total Number of Directors | 8 | ||||||||||||||||||||||
Female | Male | Non-Binary | Did Not Disclose | ||||||||||||||||||||
Gender Identity: | |||||||||||||||||||||||
Directors | 2 | 6 | 0 | 0 | |||||||||||||||||||
Demographic Background: | |||||||||||||||||||||||
African American or Black | 0 | 0 | 0 | 0 | |||||||||||||||||||
Alaskan Native or Native American | 0 | 0 | 0 | 0 | |||||||||||||||||||
Asian | 0 | 0 | 0 | 0 | |||||||||||||||||||
Hispanic or Latinx | 0 | 0 | 0 | 0 | |||||||||||||||||||
Native Hawaiian or Pacific Islander | 0 | 0 | 0 | 0 | |||||||||||||||||||
White | 2 | 5 | 0 | 0 | |||||||||||||||||||
Two or More Race Ethnicities | 0 | 1 | 0 | 0 | |||||||||||||||||||
LGBTQ+ | 0 | 0 | 0 | 1 | |||||||||||||||||||
Persons with Disabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
Name of Individual or Identity of Group | Number of Shares Owned (1) | Percentage of Class (2) | ||||||
Alfred P. West, Jr. (3) | 4,665,136 | 3.5 | ||||||
William M. Doran (4) | 9,228,501 | 7.0 | ||||||
Carmen V. Romeo (5) | 2,934,195 | 2.2 | ||||||
Ryan P. Hicke (6) | 251,499 | * | ||||||
Kathryn M. McCarthy | 115,350 | * | ||||||
Carl A. Guarino (7) | 82,071 | * | ||||||
Stephanie D. Miller | — | * | ||||||
Jonathan A. Brassington | — | * | ||||||
Dennis J. McGonigle (8) | 729,463 | * | ||||||
Wayne M. Withrow | 135,399 | * | ||||||
Philip N. McCabe | 213,609 | * | ||||||
All executive officers and directors as a group (18 persons) (9) | 19,083,422 | 14.3 | ||||||
Loralee West (10) | 12,983,619 | 9.9 | ||||||
The Vanguard Group (11) | 11,888,519 | 9.0 | ||||||
BlackRock, Inc. (12) | 11,162,525 | 8.5 | ||||||
Loomis Sayles & Co., L.P. (13) | 9,491,888 | 7.2 | ||||||
*Less than one percent. |
Grant Type | Tier 1 | Tier 2 | Tier 3 | Tier 4 | ||||||||||
Options | 11,000 | 6,500 | 3,000 | 0 | ||||||||||
RSUs | 1,100 | 700 | 500 | 500 |
Name | 2024 Base Compensation Amount ($) | % Increase | 2024 Incentive Compensation Target ($) | % Increase | ||||||||||
Ryan P. Hicke | 850,000 | 13.3% | 2,000,000 | 14.3% |
Summary Compensation Table Total | Compensation Actually Paid | Value of Initial Fixed $100 Investment Based On: | ||||||||||||||||||||||||||||||
Year | PEO 1 Ryan P. Hicke ($) (1) | PEO 2 Alfred P. West, Jr. ($) (2) | PEO 1 Ryan P. Hicke ($) (3) | PEO 2 Alfred P. West, Jr. ($) (4) | Average Summary Compensation Table Total for non-PEO NEOs ($) (5) | Average Compensation Actually Paid to non-PEO NEOs ($) (6) | SEI TSR ($) (7) | Industry Index TSR ($) (8) | Net Income ($000s) (9) | Adjusted Pre-Tax Earnings Per Share ($) (10) | ||||||||||||||||||||||
2023 | 5,934,430 | N/A | 6,142,130 | N/A | 3,050,860 | 3,080,441 | 102.46 | 181.96 | 462,258 | 4.61 | ||||||||||||||||||||||
2022 | 6,402,465 | 2,469,653 | 6,224,840 | 2,377,978 | 3,494,008 | 3,332,318 | 92.66 | 129.82 | 475,467 | 4.48 | ||||||||||||||||||||||
2021 | N/A | 2,367,239 | N/A | 2,475,614 | 1,991,178 | 2,162,026 | 95.47 | 180.24 | 546,593 | 5.12 | ||||||||||||||||||||||
2020 | N/A | 2,933,734 | N/A | 2,552,384 | 2,823,425 | 2,899,647 | 88.89 | 125.65 | 447,286 | 3.99 |
Year | 2020 | 2021 | 2022 | 2022 | 2023 | ||||||||||||
PEO | Alfred P. West, Jr. | Alfred P. West, Jr. | Alfred P. West, Jr. | Ryan P. Hicke | Ryan P. Hicke | ||||||||||||
SCT Total Compensation ($) | 2,933,734 | 2,367,239 | 2,469,653 | 6,402,465 | 5,934,430 | ||||||||||||
Less: Stock and Option Award Values Reported in SCT for the Covered Year ($) | (1,014,000) | (373,625) | (694,825) | (4,106,600) | (3,416,000) | ||||||||||||
Plus: Fair Value for Stock and Option Awards Granted in the Covered Year ($) | 988,875 | 383,000 | 628,450 | 3,941,000 | 3,544,500 | ||||||||||||
Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years ($) | (356,225) | 49,500 | 50,075 | 63,350 | 95,800 | ||||||||||||
Change in Fair Value of Stock and Option Awards from Prior Years that Vested in the Covered Year ($) | — | 49,500 | (75,375) | (75,375) | (16,600) | ||||||||||||
Compensation Actually Paid ($) | 2,552,384 | 2,475,614 | 2,377,978 | 6,224,840 | 6,142,130 |
Year | 2020 Average | 2021 Average | 2022 Average | 2023 Average | ||||||||||
Non-PEO NEOs | See column (5) note | See column (5) note | See column (5) note | See column (5) note | ||||||||||
SCT Total Compensation ($) | 2,823,425 | 1,991,178 | 3,494,008 | 3,050,860 | ||||||||||
Less: Stock and Option Award Values Reported in SCT for the Covered Year ($) | (1,280,438) | (429,669) | (1,893,842) | (637,000) | ||||||||||
Plus: Fair Value for Stock and Option Awards Granted in the Covered Year ($) | 1,994,694 | 440,450 | 1,754,833 | 663,700 | ||||||||||
Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years ($) | (638,034) | 176,488 | 52,694 | (11,369) | ||||||||||
Change in Fair Value of Stock and Option Awards from Prior Years that Vested in the Covered Year ($) | — | (16,421) | (75,375) | 14,250 | ||||||||||
Compensation Actually Paid ($) | 2,899,647 | 2,162,026 | 3,332,318 | 3,080,441 |
Pay ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annual total
| $115,346 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annual total compensation of the | $5,934,430 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ratio of annual total compensation of the | 51.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name and Principal Position | Year | Salary ($)(1) | Option Awards ($)(2) | Stock Awards ($)(3) | Non-Equity Incentive Plan Compensation ($)(4) | All Other Compensation ($)(5) | Total ($) | ||||||||||||||||
Ryan P. Hicke | 2023 | 750,000 | 1,556,000 | 1,860,000 | 1,750,000 | 18,430 | 5,934,430 | ||||||||||||||||
Chief Executive Officer | 2022 | 688,269 | 1,801,000 | 2,305,600 | 1,575,000 | 32,596 | 6,402,465 | ||||||||||||||||
2021 | 600,000 | 373,625 | — | 880,000 | 73,586 | 1,927,211 | |||||||||||||||||
Alfred P. West, Jr. | 2023 | 750,000 | 389,000 | 248,000 | 990,000 | 23,599 | 2,400,599 | ||||||||||||||||
Executive Chairman | 2022 | 750,000 | 540,300 | 154,525 | 990,000 | 34,828 | 2,469,653 | ||||||||||||||||
2021 | 750,000 | 373,625 | — | 1,210,000 | 33,614 | 2,367,239 | |||||||||||||||||
Dennis J. McGonigle | 2023 | 700,000 | — | — | 1,300,000 | 22,310 | 2,022,310 | ||||||||||||||||
Executive Vice President | 2022 | 642,692 | 1,350,750 | 1,049,000 | 1,170,000 | 31,347 | 4,243,789 | ||||||||||||||||
and Chief Financial Officer | 2021 | 600,000 | 373,625 | — | 880,000 | 30,133 | 1,883,758 | ||||||||||||||||
Wayne M. Withrow | 2023 | 700,000 | — | — | 1,050,000 | 3,823,412 | 5,573,412 | ||||||||||||||||
Executive Vice President > | 2022 | 618,846 | 1,350,750 | 1,236,200 | 1,080,000 | 34,641 | 4,320,437 | ||||||||||||||||
Head of Global Asset Management | 2021 | 600,000 | 597,800 | — | 960,000 | 33,427 | 2,191,227 | ||||||||||||||||
Philip N. McCabe | 2023 | 650,000 | 389,000 | 248,000 | 900,000 | 20,118 | 2,207,118 | ||||||||||||||||
Executive Vice President > | 2022 | 609,423 | 540,300 | 154,525 | 1,050,000 | 31,347 | 2,385,595 | ||||||||||||||||
Investment Managers | 2021 | 600,000 | 373,625 | — | 960,000 | 28,891 | 1,962,516 |
Name | Type of Award | Grant Date | All Other Stock Awards: Number of Shares of Stock or Units (#)(1) | All Other Option Awards: Number of Securities Underlying Options (#)(2) | Exercise or Base Price of Option Awards ($/Sh) | Grant Date Fair Value of Stock and Option Awards ($)(3)(4) | ||||||||||||||
Ryan P. Hicke | RSUs | 12/15/2023 | 30,000 | 1,860,000 | ||||||||||||||||
Options | 12/15/2023 | 100,000 | 62.00 | 1,556,000 | ||||||||||||||||
Alfred P. West, Jr. | RSUs | 12/15/2023 | 4,000 | 248,000 | ||||||||||||||||
Options | 12/15/2023 | 25,000 | 62.00 | 389,000 | ||||||||||||||||
Philip N. McCabe | RSUs | 12/15/2023 | 4,000 | 248,000 | ||||||||||||||||
Options | 12/15/2023 | 25,000 | 62.00 | 389,000 | ||||||||||||||||
Name | Grant Date | Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable (1) | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($) (2) | ||||||||||||||||
Ryan P. Hicke | 12/9/2014 | 20,000 | — | 40.64 | 12/9/2024 | ||||||||||||||||||
12/8/2015 | 24,000 | — | 53.34 | 12/8/2025 | |||||||||||||||||||
12/13/2016 | 35,000 | — | 49.63 | 12/13/2026 | |||||||||||||||||||
12/12/2017 | 12,500 | 12,500 | 71.12 | 12/12/2027 | |||||||||||||||||||
12/11/2018 | 17,500 | 17,500 | 48.47 | 12/11/2028 | |||||||||||||||||||
12/9/2019 | 20,000 | 20,000 | 64.43 | 12/9/2029 | |||||||||||||||||||
12/8/2020 | 37,500 | 37,500 | 56.54 | 12/8/2030 | |||||||||||||||||||
12/10/2021 | — | 25,000 | 60.46 | 12/10/2031 | |||||||||||||||||||
6/1/2022 | 30,000 | 1,906,500 | |||||||||||||||||||||
12/5/2022 | — | 100,000 | 61.81 | 12/5/2032 | |||||||||||||||||||
12/15/2023 | — | 100,000 | 62.00 | 12/15/2033 | 30,000 | 1,906,500 | |||||||||||||||||
Alfred P. West, Jr. | 12/9/2014 | 35,000 | — | 40.64 | 12/9/2024 | ||||||||||||||||||
12/8/2015 | 30,000 | — | 53.34 | 12/8/2025 | |||||||||||||||||||
12/13/2016 | 35,000 | — | 49.63 | 12/13/2026 | |||||||||||||||||||
12/12/2017 | 10,000 | 10,000 | 71.12 | 12/12/2027 | |||||||||||||||||||
12/11/2018 | 12,500 | 12,500 | 48.47 | 12/11/2028 | |||||||||||||||||||
12/9/2019 | 10,000 | 10,000 | 64.43 | 12/9/2029 | |||||||||||||||||||
12/8/2020 | 37,500 | 37,500 | 56.54 | 12/8/2030 | |||||||||||||||||||
12/10/2021 | — | 25,000 | 60.46 | 12/10/2031 | |||||||||||||||||||
12/5/2022 | — | 30,000 | 61.81 | 12/5/2032 | 2,500 | 158,875 | |||||||||||||||||
12/15/2023 | — | 25,000 | 62.00 | 12/15/2033 | 4,000 | 254,200 | |||||||||||||||||
Dennis J. McGonigle | 12/9/2014 | 27,500 | — | 40.64 | 12/9/2024 | ||||||||||||||||||
12/8/2015 | 24,000 | — | 53.34 | 12/8/2025 | |||||||||||||||||||
12/13/2016 | 25,000 | — | 49.63 | 12/13/2026 | |||||||||||||||||||
12/12/2017 | 12,500 | 12,500 | 71.12 | 12/12/2027 | |||||||||||||||||||
12/11/2018 | 12,500 | 12,500 | 48.47 | 12/11/2028 | |||||||||||||||||||
12/9/2019 | 15,000 | 15,000 | 64.43 | 12/9/2029 | |||||||||||||||||||
12/8/2020 | 37,500 | 37,500 | 56.54 | 12/8/2030 | |||||||||||||||||||
12/10/2021 | — | 25,000 | 60.46 | 12/10/2031 | |||||||||||||||||||
7/18/2022 | 15,000 | 953,250 | |||||||||||||||||||||
12/5/2022 | — | 75,000 | 61.81 | 12/5/2032 | |||||||||||||||||||
Wayne M. Withrow | 12/9/2014 | 27,500 | — | 40.64 | 12/9/2024 | ||||||||||||||||||
12/8/2015 | 30,000 | — | 53.34 | 12/8/2025 | |||||||||||||||||||
12/13/2016 | 25,000 | — | 49.63 | 12/13/2026 | |||||||||||||||||||
12/12/2017 | 10,000 | 10,000 | 71.12 | 12/12/2027 | |||||||||||||||||||
12/11/2018 | 10,000 | 10,000 | 48.47 | 12/11/2028 | |||||||||||||||||||
12/9/2019 | 10,000 | 10,000 | 64.43 | 12/9/2029 | |||||||||||||||||||
12/8/2020 | 37,500 | 37,500 | 56.54 | 12/8/2030 | |||||||||||||||||||
12/10/2021 | — | 40,000 | 60.46 | 12/10/2031 | |||||||||||||||||||
12/5/2022 | — | 75,000 | 61.81 | 12/5/2032 | 15,000 | 953,250 | |||||||||||||||||
Philip N. McCabe | 12/9/2014 | 21,000 | — | 40.64 | 12/9/2024 | ||||||||||||||||||
12/8/2015 | 24,000 | — | 53.34 | 12/8/2025 | |||||||||||||||||||
12/13/2016 | 30,000 | — | 49.63 | 12/13/2026 | |||||||||||||||||||
12/12/2017 | 12,500 | 12,500 | 71.12 | 12/12/2027 | |||||||||||||||||||
12/11/2018 | 17,500 | 17,500 | 48.47 | 12/11/2028 | |||||||||||||||||||
12/9/2019 | 20,000 | 20,000 | 64.43 | 12/9/2029 | |||||||||||||||||||
12/8/2020 | 37,500 | 37,500 | 56.54 | 12/8/2030 | |||||||||||||||||||
12/10/2021 | — | 25,000 | 60.46 | 12/10/2031 | |||||||||||||||||||
12/5/2022 | — | 30,000 | 61.81 | 12/5/2032 | 2,500 | 158,875 | |||||||||||||||||
12/15/2023 | — | 25,000 | 62.00 | 12/15/2033 | 4,000 | 254,200 |
Option Expiration Date | 50% Exercisable When Our Reported EPS Plus ASC 718 Expense Exceeds | 100% Exercisable When Our Reported EPS Plus ASC 718 Expense Exceeds | ||||||
12/12/2027 | Vested | $5.50 | ||||||
12/11/2028 | Vested | $6.00 | ||||||
12/9/2029 | Vested | $6.00 | ||||||
12/8/2030 | Vested | $5.35 | ||||||
12/10/2031 | $5.75 | $7.00 | ||||||
12/5/2032 | $5.00 | $6.25 | ||||||
12/15/2033 | $5.25 | $7.10 |
Name | Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($) | Number of shares acquired on vesting (#)(1) | Value realized on vesting ($) | ||||||||||
Ryan P. Hicke | 25,000 | 606,350 | 10,000 | 566,400 | ||||||||||
Alfred P. West, Jr. | 45,000 | 1,172,118 | — | — | ||||||||||
Dennis J. McGonigle | 30,000 | 853,935 | 5,000 | 310,900 | ||||||||||
Wayne M. Withrow | 30,000 | 819,028 | 5,000 | 300,600 | ||||||||||
Philip N. McCabe | 25,000 | 515,125 | — | — |
Benefits and Payments Upon Termination | Termination Without Cause ($) | Death or Disability ($) | ||||||
Cash Severance-Salary (1) | 1,125,000 | — | ||||||
Cash Severance-Bonus (2) | 2,625,000 | — | ||||||
RSUs-Accelerated (3) | 1,906,500 | 1,906,500 |
Name | Fees Earned or Paid in Cash ($) | Stock Awards ($)(1) | Option Awards ($)(2) | All Other Compensation ($) | Total ($) | |||||||||||||||||||||
Jonathan A. Brassington | 95,000 | 62,000 | 124,480 | — | 281,480 | |||||||||||||||||||||
William M. Doran | 92,500 | 62,000 | 124,480 | 348,004 | (3) | 626,984 | ||||||||||||||||||||
Carl A. Guarino | 112,500 | 62,000 | 124,480 | — | 298,980 | |||||||||||||||||||||
Kathryn M. McCarthy | 107,500 | 62,000 | 124,480 | — | 293,980 | |||||||||||||||||||||
Stephanie D. Miller | 21,875 | 103,755 | (4) | 245,905 | (5) | — | 371,535 | |||||||||||||||||||
Carmen V. Romeo | 112,500 | 62,000 | 124,480 | — | 298,980 |
Audit Committee report. |
Required | Because your vote is advisory, it will not be binding upon | |||||||||||||
Our compensation philosophy is designed to align each executive’s compensation with our short-term and long-term performance and to provide the compensation and incentives needed to attract, motivate, and retain key executives who are crucial to our long-term success. Shareholders are encouraged to read the Compensation Discussion and Analysis (“CD&A”) and other sections of this proxy statement regarding our compensation practices for named executive officers, which include discussions of the following: •The Compensation Committee engaged and received advice from a third-party compensation consultant concerning the compensation of our Chief Executive Officer. It selected a peer group of companies, taking into account the compensation consultant’s recommendations, to compare to our Chief Executive Officer’s compensation. •We have many compensation practices that ensure consistent leadership, decision-making and actions without taking inappropriate or unnecessary risks. The practices include: •We have an incentive compensation repayment (“clawback”) policy; •We have a stock ownership policy requiring executives to maintain a minimum value of ownership of our equity in accordance with the plan; | •With the exception of Mr. Hicke, as discussed earlier, we employ our named executive officers “at will” without severance agreements or employment contracts; •We have a long-standing insider trading policy which, among other things, prevents executive officers from buying or selling put or call options or futures on our Shares; •Our performance-based incentive programs include a balance of different measures for short-term and long-term programs; and •Our executive officers’ compensation amounts are aligned with our financial performance and the overall implementation of our business strategies. The Compensation Committee and the Board believe that these policies, procedures, and amounts are effective in implementing our compensation philosophy and in achieving its goals. This advisory shareholder vote, commonly known as “Say-on-Pay,” gives you as a Shareholder the opportunity to approve or not approve our executive compensation program and policies through the following resolution: “Resolved, that the holders of Shares of the Company approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company’s Proxy Statement for the 2024 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission including the Compensation Discussion and Analysis, the 2023 Summary Compensation Table and the other related tables and disclosure.” |
Required vote and Board recommendation | We are asking our shareholders to approve a proposal to adopt the 2024 Omnibus Equity Compensation Plan (the “2024 Plan”) at our 2024 Annual Meeting. The Board adopted on April 2, 2024, subject to shareholder approval, the 2024 Plan upon recommendation of the Compensation Committee to encourage employees, non-employee directors, and consultants of the Company and its subsidiaries to promote our growth and performance and to further align their economic interests with those of our shareholders. If approved by our shareholders, the 2024 Plan will become effective as of the date of the shareholder approval (the “Effective Date”). Our Board of Directors unanimously recommends a vote FOR approval of our 2024 Omnibus Equity Compensation Plan. | |||||||||||||
The 2024 Plan is intended to replace our 2014 Omnibus Equity Compensation Plan (the “2014 Plan”), which will expire in accordance with its terms on May 20, 2024 (the “Expiration Date”). No additional grants will be made under the 2014 Plan following the Expiration Date. Outstanding grants under the 2014 Plan will continue in effect according to their terms. If our shareholders do not approve the 2024 Plan, we will be unable to grant awards under the 2014 Plan following the Expiration Date. As of March 22, 2024, 8,732,679 Shares, were available for grant under the 2014 Plan. Our Board is seeking shareholder approval of the 2024 Plan in order to (i) meet the NASDAQ listing requirements, (ii) allow incentive stock options awarded under the 2024 Plan to meet the requirements of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder (the “Code”), (iii) maintain a limit on annual compensation of non-employee directors, and (iv) conform to good corporate governance. | Why We Are Seeking Approval of the 2024 Plan Equity incentive compensation plays a key role in the Company’s efforts to attract and retain key personnel essential to the Company’s long-term growth and financial success. We are asking our shareholders to approve the 2024 Plan to assist the Company in attracting, motivating, and retaining highly qualified employees, directors, and consultants by offering a competitive compensation program that is linked to the performance of our Shares. Offering a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive fintech and asset management industry. We use equity awards to increase incentives on the part of employees, directors, and consultants who provide important services to the Company. We believe that providing an equity stake in the future success of our Company motivates these individuals to achieve our long-term business goals and to increase shareholder value. Their innovation and productivity are critical to our success. Accordingly, approving the 2024 Plan is in the best interest of our shareholders because equity awards help us to: |
Potential Overhang with 6,500,000 Requested Shares | |||||
Stock Options Outstanding as of March 22, 2024(1) | 16,119,998 | ||||
Weighted Average Exercise Price of Stock Options Outstanding as of March 22, 2024 | $58.77 | ||||
Weighted Average Remaining Term of Stock Options Outstanding as of March 22, 2024 | 6.3 years | ||||
Full Value Awards Outstanding as of March 22, 2024(2) | 819,062 | ||||
Total Equity Awards Outstanding as of March 22, 2024(3) | 16,939,060 | ||||
Shares Available for Grant under the 2014 Plan as of March 22, 2024 | 8,732,679 | ||||
Shares Requested for the 2024 Plan | 6,500,000 | ||||
Total Potential Overhang under the 2024 Plan(4) | 32,171,739 | ||||
Shares of Common Stock Outstanding as of March 22, 2024 | 131,516,973 | ||||
Fully Diluted Shares(5) | 163,188,712 | ||||
Potential Dilution of 6,500,000 Shares as a Percentage of Fully Diluted Shares | 3.97% |
Element | 2023 | 2022 | 2021 | 3-Year Average | ||||||||||
Stock Options Granted(1) | 1,871,800 | 2,215,000 | 3,323,700 | 2,470,166 | ||||||||||
Full Value Awards Granted(2) | 373,366 | 467,262 | 0 | 280,209 | ||||||||||
Weighted Average Shares of Common Stock Outstanding as of applicable fiscal year-end | 132,593,460 | 136,071,382 | 141,215,621 | 136,626,821 | ||||||||||
Value Adjusted Burn Rate | 1.69% | 1.97% | 2.35% | 2.01% |
Required vote and Board recommendation | The affirmative vote of a majority of the votes cast at our 2024 Annual Meeting by the holders of the outstanding Shares is required for the ratification of this appointment. Our Board unanimously recommends that Shareholders vote FOR approval of this proposal. | |||||||||||||
The Audit Committee of our Board has selected KPMG LLP (“KPMG”) | ultimate authority with respect to the selection of | |||||||||||||
The following is a summary of the fees KPMG billed to |
Fee Category | 2023 | 2022 | ||||||||||||
Audit Fees (1) | $6,400,314 | $5,684,843 | ||||||||||||
Audit-related Fees (2) | 2,019,166 | 1,653,844 | ||||||||||||
Tax Fees (3) | 81,568 | 332,212 | ||||||||||||
All Other Fees | 177,367 | 3,800 | ||||||||||||
$8,678,415 | $7,674,699 | |||||||||||||
(1)Audit fees for the years ended December 31, 2023 and 2022, respectively, were for professional services rendered for the audits and interim quarterly reviews of our consolidated financial statements and other statutory and subsidiary audits. Audit fees for the year ended December 31, 2023 and 2022 also include fees billed by KPMG for audits of our various Collective Trust Funds. These fees were paid by the various funds. (2)Audit-related fees for the year ended December 31, 2023 and 2022, respectively, were for attestation services, internal control reviews and other audit-related services. (3)Tax fees for the years ended December 31, 2023 and 2022, respectively, were for tax compliance and due diligence services, including the review or preparation of foreign tax returns, and general tax planning services. |
Fee Category | 2015 | 2014 | ||||
Audit Fees (1) | $3,364,000 | $2,924,850 | ||||
Audit-related Fees (2) | 378,286 | 352,671 | ||||
Tax Fees (3) | 8,721 | 148,179 | ||||
All Other Fees (4) | 38,700 | 24,370 | ||||
$3,789,707 | $3,450,070 |
Other important information. Sustainability practices These practices benefit the environment by minimizing the use of paper and printing and lower our costs. Request electronic access to proxy materials and annual reports If you receive your proxy materials by mail, we encourage you to elect electronic delivery. If you do, you will receive an email with links to access the Proxy Statement and Annual Report on the Internet. If you are a beneficial shareholder, please contact your broker, bank, or nominee to request electronic access to proxy materials. If your shares are registered in your name, please access www.proxyvote.com to vote. You will have the option to enroll in electronic delivery immediately after casting your vote. Reduce duplicate mailings We deliver a single Proxy Statement and Annual Report, along with individual proxy cards, to shareholders who have not enrolled in electronic delivery and share the same address, unless we have received contrary instructions. This practice is known as “householding.” To discontinue householding and receive separate copies of proxy materials, beneficial shareholders should contact their broker, bank, or nominee where their account is held, and registered shareholders should contact their account holder or our transfer agent, Equiniti Trust Company, LLC, by phone at (800) 937-5449 or by email at help@equiniti.com. Access available information about us We publish our earnings releases on our website at seic.com/investor-relations, as well as make available to shareholders the opportunity to listen to our quarterly earning calls. Our website also provides free-of-charge access to our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports as soon as reasonably practicable after such materials are filed with the Securities and Exchange Commission (SEC). Our website and our filings made with the SEC are not part of this Proxy Statement. References to our website address in this Proxy Statement are intended to be inactive textual references only. Delinquent Section 16(a) reports Section 16(a) of the Exchange Act requires our directors and executive officers and any beneficial owner of more than 10% of any class of our equity securities to file with the SEC initial reports of beneficial ownership and reports of changes in ownership of any of our securities. These reports are made on documents referred to as Forms 3, 4 and 5. Our directors and executive officers must also provide us with copies of these reports. We have reviewed the copies of the reports that we have received and any written representations that no Form 5 was required from the individuals required to file the reports that we have received, as well as reviewed Forms 3, 4 and 5 filed with the SEC. Based on this review, we believe that during the year ended December 31, 2023, each of our directors and executive officers and beneficial owners of more than 10% of any class of our equity securities timely complied with applicable reporting requirements for transactions in our equity securities, except for certain reports that were filed late, as follows: Ms. Blumenstein – one late Form 4 relating 2024 Proxy Statement 69 to a total of fourteen transactions; Mr. Brassington – one late Form 3 and one late Form 4 relating to a total of five transactions; Mr. Doran – two late Form 4s relating to a total of five transactions; Mr. Guarino – one late Form 4 relating to a total of three transactions; Mr. Hicke – one Form 3 amendment; Mr. McCabe – one late Form 3; Ms. McCarthy – one late Form 4 relating to a total of three transactions; Mr. McGonigle – two late Form 4s relating to a total of four transactions; Mr. Peterson – one late Form 4 relating to a total of three transactions; Mr. Romeo – one late Form 4 relating to a total of three transactions; Mr. Sharma – one late Form 3 and one late Form 4 relating to a total of five transactions; Mr. West – two late Form 4s relating to a total of four transactions; and Mr. Withrow – two late Form 4s relating to a total of five transactions. Solicitation of proxies The accompanying proxy card is solicited on behalf of our Board. Following the original mailing of the proxy materials, proxies may be solicited personally by our officers and employees, who will not receive additional compensation for these services. We will reimburse banks, brokerage firms, and other custodians, nominees, and fiduciaries for reasonable expenses incurred by them in sending proxy materials to beneficial shareholders. Nominations and proposals by shareholders for our 2025 Annual Meeting Proposals that Shareholders wish to have considered for possible inclusion in our Proxy Statement for the 2025 Annual Meeting must be received by our Secretary at our principal offices (One Freedom Valley Drive, Oaks, PA 19456-1100) no later than December 16, 2024. If you wish to submit a proposal for a vote or to nominate a candidate for election as director at the 2025 Annual Meeting (but not seek inclusion of the proposal or nomination in our Proxy Statement), we must receive your proposal or nomination, in accordance with our Bylaws, on or before February 28, 2025, but not before January 29, 2025. Shareholders who submit nominations for director and who intend to solicit proxies in support of their nominees must include in their submission all information required by Rule 14a-19 under the Exchange Act. Additional information We will provide without charge to any person from whom a proxy is solicited by our Board, upon the written request of such person, a copy of our 2023 Annual Report on Form 10-K, including the financial statements and schedules thereto, required to be filed with the Securities and Exchange Commission pursuant to Rule 13a-1 under the Exchange Act. Any such requests should be directed to Michael Peterson, General Counsel, at our principal offices at 1 Freedom Valley Drive, Oaks, PA 19456-1100, phone: (610) 676-1000. Forward-looking statements This proxy statement contains forward-looking statements within the meaning or the rules and regulations of the Securities and Exchange Commission. In some cases you can identify forward-looking statements by terminology, such as ‘‘may,’’ ‘‘will,’’ ‘‘expect,’’ ‘‘believe’’ and ‘‘continue,’’ or ‘‘appear.’’ Our forward-looking statements include our current expectations as to our growth, strategies and the opportunities for our success. You should not place undue reliance on our forward-looking statements, as they are based on the current beliefs and expectations of our management and subject to significant risks and uncertainties, many of which are beyond our control or are subject to change. Although we believe the assumptions upon which we base our forward-looking statements are reasonable, they could be inaccurate. Some of the risks and important factors that could cause actual results to differ from those described in our forward-looking statements can be found in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission. 70 2024 Proxy Statement Annex A SEI INVESTMENTS COMPANY Reconciliation of GAAP to Non-GAAP Measure The Adjusted Pre-Tax Earnings Per Share results reflected in the “Pay Versus Performance” section of this Proxy Statement is a non-GAAP financial measure. This non-GAAP financial measure should be viewed in addition to, and not as a substitute for, reported results prepared in accordance with GAAP. Please refer to the Company's annual reports on Form 10-K for terms not defined herein. The Compensation Committee utilizes this non-GAAP measure when determining whether vesting targets for outstanding stock options have been met. This non-GAAP measure is adjusted to exclude the impact of certain costs, expenses, and revenue, the exclusion of which the Compensation Committee believes provides an understanding of the results of the primary operations of the Company’s businesses and enhances comparability across fiscal reporting periods. Neither the Compensation Committee nor management utilize Adjusted Pre-Tax Earnings Per Share for the compensation processes related to the Company’s employees or any other purpose. The following table reconciles financial results reported in accordance with generally accepted accounting principles (GAAP) to the non-GAAP financial measure presented in this Proxy Statement. Reconciliation of Diluted Earnings Per Share to Adjusted Pre-Tax Earnings Per Share
2024 Proxy Statement 71 Annex B SEI INVESTMENTS COMPANY 2024 Omnibus equity compensation plan 1.Purpose Effective as of the Effective Date, the SEI Investments Company 2024 Omnibus Equity Compensation Plan (the “Plan”) is hereby established as a successor to the SEI Investments Company 2014 Omnibus Equity Compensation Plan (the “2014 Plan”). No additional grants shall be made after the Effective Date under the 2014 Plan. Shares of Company Stock authorized under the 2014 Plan but not subject to awards that have been granted prior to or as of the Effective Date shall be available for issuance or transfer under this Plan. Outstanding grants under the 2014 Plan shall continue in effect according to their terms as in effect before the Effective Date (subject to such amendments as the Committee determines, consistent with the 2014 Plan, as applicable), and the shares with respect to outstanding grants under the 2014 Plan shall not be issued or transferred under this Plan. The purpose of the Plan is to provide designated (i) Employees of the Company and its subsidiaries, (ii) Non-Employee Directors and (iii) Consultants who perform services for the Company and its subsidiaries with the opportunity to receive grants of Options, Stock Units, Stock Awards, SARs and Other Stock-Based Awards. The Company believes that the Plan will encourage the Participants to contribute materially to the growth of the Company, thereby benefiting the Company’s shareholders, and will align the economic interests of the Participants with those of the shareholders. All capitalized terms shall be as defined in Section 2 below. 2.Definitions Whenever used in this Plan, the following terms will have the respective meanings set forth below: (a)“Board” means the Company’s Board of Directors. (b)“Cause” has the meaning set forth in a written employment, severance or other agreement or plan between the Participant and the Employer or, if there is no such agreement or plan or no such definition, Cause means (i) an act of material dishonesty by the Participant in connection with the Participant’s responsibilities as an Employee, Non-Employee Director, or Consultant, (ii) the Participant’s conviction of, or plea of nolo contendere to, a felony, (iii) the Participant’s gross misconduct in connection with the Participant’s responsibilities as an Employee, Non-Employee Director, or Consultant, (iv) fraud, embezzlement, or misappropriation of any amounts of money or assets or property of the Company, (v) the Participant’s violation of the written policies or procedures of the Company or a subsidiary, as applicable; or (vi) the Participant’s continued failure to perform his or her responsibilities as an Employee, Non-Employee Director, or Consultant after the Participant has received a written demand for such performance. (c)“Change of Control” shall be deemed to have occurred if: (i)any “person” (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the voting power of the then outstanding securities of the Company; provided that a Change of Control shall not be deemed to occur as a result of a transaction in which the Company becomes a subsidiary of another corporation and in which the shareholders of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares entitling such shareholders to more than 50% of all votes to which all shareholders of the parent corporation would be entitled in the election of directors; (ii)the consummation of (1) a merger or consolidation of the Company with another corporation where the shareholders of the Company, immediately prior to the merger or consolidation, will not beneficially own, immediately after the merger or consolidation, shares entitling such shareholders to more than 50% of all votes to which all shareholders of the surviving 72 2024 Proxy Statement corporation would be entitled in the election of directors, (2) a sale or other disposition of all or substantially all of the assets of the Company, or (3) a liquidation or dissolution of the Company; or (iii)after the Effective Date, directors are elected such that a majority of the members of the Board shall have been members of the Board for less than one year, unless the election or nomination for election of each new director who was not a director at the beginning of such one-year period was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of such period. Notwithstanding the foregoing, for any Grants subject to the requirements of section 409A of the Code that will become payable on a Change of Control, the transaction constituting a “Change of Control” must also constitute a “change in control event” for purposes of section 409A(a)(2)(A)(v) of the Code. (d)“Code” means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder. (e)“Committee” means the Compensation Committee of the Board. The Committee shall be comprised of not less than such number of Directors as shall be required to permit Grants granted under the Plan to qualify under Rule 16b-3 of the Exchange Act, and each member of the Committee shall be a “Non-Employee Director” within the meaning of Rule 16b-3 of the Exchange Act. (f)“Company” means SEI Investments Company and any successor corporation. (g)“Company Stock” means the common stock of the Company, par value $0.01 per share. (h)“Consultants” means any consultant or advisor who performs bona fide services for the Employer; provided that the consultant or advisor renders bona fide services to the Employer, the services are not in connection with the offer and sale of securities in a capital-raising transaction, and the consultant or advisor does not directly or indirectly promote or maintain a market for the Company’s securities. (i)“Disability” or “Disabled” means the Participant has been determined to be eligible to receive long-term disability benefits under the Company’s long-term disability plan, or if no such plan is applicable to the participant, the term shall mean the Participant’s becoming disabled within the meaning of Section 22(e)(3) of the Code. (j)“Dividend Equivalent” means an amount calculated with respect to a Stock Unit, which is determined by multiplying the number of shares of Company Stock subject to the Stock Unit by the per-share cash dividend, or the per-share Fair Market Value (as determined by the Committee) of any dividend in consideration other than cash, paid by the Company on its Company Stock. If interest is credited on accumulated dividend equivalents, the term “Dividend Equivalent” shall include the accrued interest. (k)“Effective Date” means the date the Plan is approved by the Company’s shareholders. (l)“Employee” means an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified by the Employer as a “contractor” or “consultant,” no matter how characterized by the Internal Revenue Service, other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the Committee determines otherwise. (m)“Employer” means the Company and each of its subsidiaries that acts as the employer or service recipient for a Participant. (n)“Exchange Act” means the Securities Exchange Act of 1934, as amended. (o)“Exercise Price” means the per share price at which shares of Company Stock may be purchased under an Option, as designated by the Committee. (p)“Fair Market Value” of Company Stock means (i) if the principal trading market for the Company Stock is a national securities exchange, the last reported sale price of Company Stock during regular trading hours on the relevant date or (if there were no trades on that date) the last reported sale price of Company Stock during regular trading hours on the latest preceding date upon which a sale was reported, (ii) if the Company Stock is not principally traded on such exchange, the mean between the last reported “bid” and “asked” prices of Company Stock on the relevant date, as reported on the OTC Bulletin Board, or (iii) if the Company Stock is not publicly traded or, if publicly traded, is not so reported, the Fair Market Value per share shall be as determined by the Committee. (q)“Full Value Award” means a Grant other than an Option or SAR, which is settled by the issuance of Company Stock. (r)“Good Reason” has the meaning set forth in a written employment, severance or other agreement or plan between the Participant and the Employer or, if there is no such agreement or plan or no such definition, means, the occurrence of one or more of 2024 Proxy Statement 73 the following, without Participant’s consent: (i) a material diminution of the Participant’s authority, duties or responsibilities; or (ii) a material diminution in the Participant’s base compensation or annual bonus opportunity of more than 10% (other than an across the board reduction to similarly situated employees). The Participant must provide written notice of termination for Good Reason to the Employer that employs the Participant within 30 days after the event constituting Good Reason. The Employer shall have a period of 30 days in which it may correct the act or failure to act that constitutes the grounds for Good Reason as set forth in the Participant’s notice of termination. If the Employer does not correct the act or failure to act, the Participant must terminate his or her employment for Good Reason within 30 days after the end of the cure period, in order for the termination to be considered a Good Reason termination. (s)“Grant” means an Option, Stock Unit, Stock Award, SAR, Dividend Equivalent, or Other Stock-Based Award granted under the Plan. (t)“Grant Agreement” means the written instrument that sets forth the terms and conditions of a Grant, including all amendments thereto. (u)“Incentive Stock Option” means an Option that is intended to meet the requirements of an incentive stock option under section 422 of the Code. (v)“Non-Employee Director” means a member of the Board who is not an Employee. (w)“Nonqualified Stock Option” means an Option that is not intended to meet the requirements of section 422 of the Code. (x)“Option” means an Incentive Stock Option or Nonqualified Stock Option, as described in Section 7. (y)“Other Stock-Based Award” means any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit, Stock Award or SAR), as described in Section 11. (z)“Participant” means an Employee, Non-Employee Director or Consultant designated by the Committee to receive a Grant under the Plan. (aa)“Prior Plan Expiration Date” means May 20, 2024, the day on which the 2014 Plan expires. (bb) “SAR” means an award of a stock appreciation right, as described in Section 10. (cc) “Stock Award” means an award of Company Stock as described in Section 9. (dd) “Stock Unit” means an award of a contractual right to receive one or more shares of Company Stock, cash or combination thereof, as described in Section 8, and denominated in a number of shares of Company Stock specified in a Grant Agreement. (ee) “Substitute Grants” means shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted awards of a company acquired by the Company in a transaction. 3.Administration (a)Committee. Subject to Section 3(b), the Plan shall be administered and interpreted by the Committee. Ministerial functions may be performed by an administrative committee comprised of Company employees appointed by the Committee. (b)Delegation to CEO. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all or part of its authority and power to the Company’s Chief Executive Officer (“CEO”), as it deems appropriate, with respect to Grants to Employees or Consultants who are not executive officers or directors subject to the requirements of section 16 of the Exchange Act. (c)Committee Authority. The Committee shall have the sole authority to (i) determine the Participants to whom Grants shall be made under the Plan, (ii) determine the type, size and terms and conditions of the Grants to be made to each such Participant, (iii) determine the time when the Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and the acceleration of exercisability, (iv) amend the terms and conditions of any previously issued Grant, subject to the provisions of Section 18 below, and (v) deal with any other matters arising under the Plan. (d)Committee Determinations. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee’s interpretations of the Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be 74 2024 Proxy Statement conclusive and binding on all persons having any interest in the Plan or in any Grant awarded hereunder. All powers of the Committee shall be executed in its sole discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform as to similarly situated Participants. 4.Grants (a)Terms of Grants. Grants under the Plan may consist of Options as described in Section 7, Stock Units as described in Section 8, Stock Awards as described in Section 9, SARs as described in Section 10 and Other Stock-Based Awards as described in Section 11. All Grants shall be subject to the terms and conditions set forth herein and to such other terms and conditions consistent with the Plan as the Committee deems appropriate and as are specified in writing by the Committee to the Participant in the Grant Agreement or an amendment to the Grant Agreement. Grants under a particular Section of the Plan need not be uniform as among the Participants. All Grants shall be made conditional upon the Participant’s acknowledgment, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such Grant. (b)Minimum Vesting. Grants granted under the Plan shall include vesting schedules that provide that no portion of a Grants shall vest earlier than one year from the date of grant. However, (i) for purposes of Grants granted to Non-Employee Directors, such Grants shall be deemed to satisfy this minimum vesting requirement if such Grants are granted on the date of the Company’s annual meeting of shareholders and vest on the date of the Company’s annual meeting of shareholders immediately following the date of grant (but not less than 50 weeks following the date of grant), and (ii) subject to adjustments made in accordance with Sections 5(b) and 5(e) below, up to five percent (5%) of the shares of Company Stock authorized under the Plan as set forth in Section 5(a) as of the Effective Date may be granted without regard to this minimum vesting requirement. (c)Dividends and Dividend Equivalents. Notwithstanding anything to the contrary herein, any dividends or Dividend Equivalents granted in connection with any Grant under the Plan shall vest and be paid only if and to the extent the underlying Grant vests and is paid. 5.Shares Subject to the Plan (a)Shares Authorized. Subject to adjustment as described in Sections 5(b) and 5(e) below, the total aggregate number of shares of Company Stock that may be issued or transferred under the Plan shall be (i) 6,500,000 shares of Company Stock, plus (ii) the number of shares of the Company Stock reserved for issuance under the 2014 Plan that remain available for grant under the 2014 Plan as of the Prior Plan Expiration Date, plus (iii) the number of shares of Company Stock underlying any outstanding award granted under the 2014 Plan that, following the Prior Plan Expiration Date, expires, or is terminated, surrendered, cancelled or forfeited for any reason without issuance of such shares shall be available for new Grants under this Plan. Subject to adjustment as described below in Sections 5(b) and 5(d) below, the aggregate number of shares of Company Stock that may be issued or transferred under the Plan pursuant to Incentive Stock Options shall not exceed 15,232,679 shares of Company Stock. (b)Source of Shares; Share Counting. Shares of Company Stock issued or transferred under the Plan may be authorized but unissued shares of Company Stock or reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. Each share of Company Stock that is actually issued or transferred pursuant to a Full Value Award will count as three shares against the share limits in subsection (a) (i.e. on a 1:3 ratio) and each share of Company Stock that is actually issued or transferred pursuant to a Grant other than Full Value Award (other than a Grant paid in cash) will count as one share against the share limits in subjection (a) (i.e. on a 1:1 ratio). If and to the extent Options or SARs granted under the Plan (including stock options granted under the 2014 Plan) terminate, expire, or are canceled, forfeited, exchanged or surrendered without having been exercised, and if and to the extent that any Stock Awards, Stock Units, or Other Stock-Based Awards are forfeited or terminated, or otherwise are not paid in full, the shares reserved for such Grants shall again be available for purposes of the Plan, taking into account the ratios described above. If shares of Company Stock otherwise issuable under the Plan are surrendered in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall be reduced only by the net number of shares of Company Stock actually issued by the Company upon such exercise and not by the gross number of shares as to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of shares of Company Stock available for issuance under the Plan shall be reduced by only by the net number of shares of Company Stock actually issued by the Company upon such exercise. If shares of Company Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with the issuance, vesting or exercise of any Award or the issuance of Company Stock thereunder, then the number of shares of Company Stock available for issuance under the Plan shall be reduced by the net number of shares of Company Stock issued, vested or exercised under such Award, calculated in each instance after payment of such share withholding. To the extent 2024 Proxy Statement 75 any Grants are paid in cash, and not in shares of Company Stock, any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. (c)Substitute Grants. Substitute Grants shall not reduce the number of shares of Company Stock available under the Plan and available shares under a shareholder approved plan of an acquired company (as appropriately adjusted to reflect the transaction) may be used for Grants under this Plan and shall not reduce this Plan’s share reserve (subject to applicable stock exchange listing rules and Code requirements). Additionally, in the event that a company acquired by the Company or any affiliate with which the Company or any subsidiary combined has shares available under a preexisting plan approved by shareholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such preexisting plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Grants under the Plan and shall not reduce the number of shares of Company Stock authorized for grant under the Plan (and shares of Company Stock subject to such Grants shall not be added to the shares of Company Stock available for Grants under the Plan as provided in Section 5(a)); provided that Grants using such available shares shall not be made after the date awards or grants could have been made under the terms of the preexisting plan, absent the acquisition or combination, and shall only be made to individuals who were not employees or directors prior to such acquisition or combination. Notwithstanding the foregoing, Substitute Grants issued in connection with the assumption of, or in substitution for, outstanding options intended be an Incentive Stock Option within the meaning of Section 422 of the Code shall be counted against the aggregate number of shares of Company Stock available for the grant of Incentive Stock Options under the Plan. (d)Individual Limits for Non-Employee Directors. Subject to adjustment as described below in Section 5(e), the maximum aggregate grant date value of shares of Company Stock subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash fees earned by such Non-Employee Director for services rendered during the calendar year, shall not exceed $800,000 in total value. For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial reporting purposes. (e)Adjustments. If there is any change in the number or kind of shares of Company Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization, stock split, or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company’s receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or the Company’s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Company Stock available for issuance or transfer under the Plan, the maximum number and kind of shares of Company Stock for which any individual may receive Grants in any year, the number and kind of shares covered by outstanding Grants, the number and kind of shares issued or transferred and to be issued or transferred under the Plan, and the price per share or the applicable market value of such Grants shall be equitably adjusted by the Committee, in such manner as the Committee determines in its discretion to be appropriate, to reflect any increase or decrease in the number of, or change in the kind of, the issued or transferred shares of Company Stock to preclude, to the extent practicable, the enlargement or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting from such adjustment shall be eliminated. In addition, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria included in, Grants in recognition of unusual or nonrecurring events (including, without limitation, events described in the preceding sentence, and acquisitions and dispositions of businesses and assets) affecting the Company, any subsidiary or any business unit, or the financial statements of the Company or any subsidiary, or in response to changes in applicable laws, regulations, or accounting principles. In addition, in the event of a Change of Control of the Company, the provisions of Section 16 of the Plan shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A and 424 of the Code, to the extent applicable. Subject to Section 18(b), the adjustments of Grants under this Section 5(e) shall include adjustment of shares, Exercise Price of Options, base amount of SARs, any applicable performance goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final, binding and conclusive. 6.Eligibility for Participation (a)Eligible Persons. All Employees, Non-Employee Directors and Consultants shall be eligible to participate in the Plan. (b)Selection of Participants. The Committee shall select the Employees, Non-Employee Directors and Consultants to receive Grants and shall determine the number of shares of Company Stock subject to each Grant. 76 2024 Proxy Statement 7.Options (a)General Requirements. The Committee may grant Options to an Employee, Non-Employee Director or Consultants upon such terms and conditions as the Committee deems appropriate under this Section 7. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees, Non-Employee Directors and Consultants. (b)Type of Option, Price and Term. (i)The Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms and conditions set forth herein. Incentive Stock Options may be granted only to Employees of the Company or its parents or subsidiaries, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors or Consultants. (ii)The Exercise Price of Company Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary, as defined in section 424 of the Code, unless the Exercise Price per share is not less than 110% of the Fair Market Value of the Company Stock on the date of grant. (iii)The Committee shall determine the term of each Option, which shall not exceed ten years from the date of grant. However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary, as defined in section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited by applicable law, including a prohibition on purchases or sales of Company Stock under the Company’s insider trading policy, the term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise. (c)Exercisability of Options. (i)Subject to Section 4(b), Options shall become exercisable in accordance with such terms and conditions as may be determined by the Committee and specified in the Grant Agreement. The Committee may grant Options that are subject to achievement of performance goals or other conditions. The Committee may accelerate the exercisability of any or all outstanding Options at any time for any reason. (ii)Options granted to persons who are non-exempt Employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may become exercisable, as determined by the Committee, upon the Participant’s death, Disability or retirement, or upon a Change of Control or other circumstances permitted by applicable regulations). (d)Termination of Employment or Service. Except as provided in the Grant Agreement, an Option may only be exercised while the Participant is actively employed by the Employer, or actively providing service as a Non-Employee Director or Consultant; provided that for this purpose a Participant shall not be considered actively employed by or actively providing services to the Employer during any paid notice or severance period. The Committee shall determine in the Grant Agreement under what circumstances and during what time periods a Participant may exercise an Option after termination of active employment or active service. (e)Exercise of Options. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise to the Company. The Participant shall pay the Exercise Price for the Option (i) in cash or by check, (ii) if permitted by the Committee, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the date of exercise equal to the Exercise Price or by attestation to ownership of shares of Company Stock having an aggregate Fair Market Value on the date of exercise equal to the Exercise Price, (iii) by payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) with approval of the Committee, by surrender of all or any part of the vested shares of Company Stock for which the Option is exercisable to the Company for an appreciation distribution payable in shares of Company Stock with a Fair Market Value at the time of the Option surrender equal to the dollar amount by which the then Fair Market Value of the shares of Company Stock subject to the surrendered portion exceeds the aggregate Exercise Price payable for those shares, or (v) by such other method as the Committee may approve, to the extent permitted by applicable law. Shares of Company Stock used to exercise an Option shall have been held by the Participant for the requisite period of time to avoid adverse accounting consequences to the Company with respect to the Option. Payment for the shares pursuant to the Option, and any required withholding taxes, must be 2024 Proxy Statement 77 received by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance of the Company Stock. (f)Limits on Incentive Stock Options. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Company Stock on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, as defined in section 424 of the Code, exceeds $100,000, then the Option, as to the excess, shall be treated as a Nonqualified Stock Option. An Incentive Stock Option shall not be granted to any person who is not an Employee of the Company or a parent or subsidiary, as defined in section 424 of the Code. 8.Stock Units (a)General Requirements. The Committee may grant Stock Units to an Employee, Non-Employee Director or Consultant, upon such terms and conditions as the Committee deems appropriate under this Section 8. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount based on the value of a share of Company Stock. All Stock Units shall be credited to bookkeeping accounts on the Company’s records for purposes of the Plan. (b)Terms of Stock Units. The Committee may grant Stock Units that are payable on terms and conditions determined by the Committee, which may include payment based on achievement of performance goals. Subject to Section 4(b), Stock Units may be paid at the end of a specified vesting or performance period, or payment may be deferred to a date authorized by the Committee. The Committee shall determine the number of Stock Units to be granted and the requirements applicable to such Stock Units. (c)Payment With Respect to Stock Units. Payment with respect to Stock Units shall be made in cash, in Company Stock, or in a combination of the two, as determined by the Committee. The Grant Agreement shall specify the maximum number of shares that can be issued under the Stock Units. (d)Requirement of Employment or Service. The Committee shall determine in the Grant Agreement under what circumstances a Participant may retain Stock Units after termination of the Participant’s employment or service, and the circumstances under which Stock Units may be forfeited. (e)Dividend Equivalents. The Committee may grant Dividend Equivalents in connection with Stock Units, subject to Section 4(c), under such terms and conditions as the Committee deems appropriate. Dividend Equivalents shall be paid to Participants as and when the underlying Stock Units are payable, or shall be deferred. All Dividend Equivalents shall be credited to bookkeeping accounts on the Company’s records for purposes of the Plan. Dividend Equivalents may be accrued as a cash obligation, or may be converted to additional Stock Units for the Participant, and deferred Dividend Equivalents may accrue interest, all as determined by the Committee. The Committee may provide that Dividend Equivalents shall be payable based on the achievement of specific performance goals. Dividend Equivalents may be payable in cash or shares of Company Stock or in a combination of the two, as determined by the Committee. 9.Stock Awards (a)General Requirements. The Committee may issue shares of Company Stock to an Employee, Non-Employee Director or Consultant under a Stock Award, upon such terms and conditions as the Committee deems appropriate under this Section 9. Shares of Company Stock issued pursuant to Stock Awards may be issued for cash consideration or for no cash consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may establish conditions under which restrictions on Stock Awards shall lapse over a period of time, subject to Section 4(b), or according to such other criteria as the Committee deems appropriate, including restrictions based upon the achievement of specific performance goals. The Committee shall determine the number of shares of Company Stock to be issued pursuant to a Stock Award. (b)Requirement of Employment or Service. The Committee shall determine in the Grant Agreement under what circumstances a Participant may retain Stock Awards after termination of the Participant’s employment or service, and the circumstances under which Stock Awards may be forfeited. (c)Restrictions on Transfer. While Stock Awards are subject to restrictions, a Participant may not sell, assign, transfer, pledge or otherwise dispose of the shares of a Stock Award except upon death as described in Section 15(a). If certificates are issued, each certificate for a share of a Stock Award shall contain a legend giving appropriate notice of the restrictions in the Grant. The Participant shall be entitled to have the legend removed when all restrictions on such shares have lapsed. The Company may retain possession of any certificates for Stock Awards until all restrictions on such shares have lapsed. 78 2024 Proxy Statement (d)Right to Vote and to Receive Dividends. The Committee shall determine to what extent, and under what conditions, the Participant shall have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares during the restriction period. Dividends on Stock Awards shall be withheld while the Stock Awards are subject to restrictions and that the dividends shall be payable only upon the lapse of the restrictions on the Stock Awards, or on such other terms as the Committee determines. Dividends that are not paid currently shall be credited to bookkeeping accounts on the Company’s records for purposes of the Plan. Accumulated dividends may accrue interest, as determined by the Committee, and shall be paid in cash, shares of Company Stock, or in such other form as dividends are paid on Company Stock, as determined by the Committee. 10.Stock Appreciation Rights (a)General Requirements. The Committee may grant SARs to Employees, Non-Employee Directors or Consultants separately or in tandem with an Option. The Committee shall establish the number of shares, the terms and the base amount of the SAR at the time the SAR is granted. The base amount of each SAR shall be not less than the Fair Market Value of a share of Company Stock as of the date of grant of the SAR. (b)Tandem SARs. The Committee may grant tandem SARs either at the time the Option is granted or at any time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be granted only at the date of the grant of the Incentive Stock Option. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock. (c)Exercisability; Term. A SAR shall become exercisable in accordance with such terms and conditions as may be specified. Subject to Section 4(b), the Committee may grant SARs that are subject to achievement of performance goals or other conditions. The Committee may accelerate the exercisability of any or all outstanding SARs at any time for any reason. The Committee shall determine in the Grant Agreement under what circumstances and during what periods a Participant may exercise a SAR after termination of employment or service. A tandem SAR shall be exercisable only while the Option to which it is related is exercisable. The Committee shall determine the term of each SAR, which shall not exceed ten years from the date of grant. Notwithstanding the foregoing, in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a prohibition on purchases or sales of Company Stock under the Company’s insider trading policy, the term shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise. (d)Grants to Non-Exempt Employees. SARs granted to persons who are non-exempt Employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may become exercisable, as determined by the Committee, upon the Participant’s death, Disability or retirement, or upon a Change of Control or other circumstances permitted by applicable regulations). (e)Exercise of SARs. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as specified in the Grant Agreement. (f)Form of Payment. The Committee shall determine whether the stock appreciation for a SAR shall be paid in the form of shares of Company Stock, cash or a combination of the two. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock shall be valued at their Fair Market Value on the date of exercise of the SAR. If shares of Company Stock are to be received upon exercise of a SAR, cash shall be delivered in lieu of any fractional share. 11.Other Stock-Based Awards The Committee may grant other awards not specified in Sections 7, 8, 9 or 10 above that are based on or measured by Company Stock to Employees, Non-Employee Directors and Consultants, on such terms and conditions as the Committee deems appropriate. Subject to Section 4(b), Other Stock-Based Awards may be granted subject to achievement of performance goals or other conditions and may be payable in Company Stock or cash, or in a combination of the two, as determined by the Committee in the Grant Agreement. 2024 Proxy Statement 79 12.Performance-Based Awards (a)General Requirements. The Committee may determine that Options, Stock Units, Stock Awards, Dividend Equivalents or Other Stock-Based Awards granted to an Employee shall be subject to performance goals or in the form of performance-based Grants. When making Grants that are subject to performance goals, the Committee may establish (i) the performance goals that must be met, (ii) the period during which performance will be measured, (iii) the maximum amounts that may be paid if the performance goals are met, and (iv) any other conditions or terms that the Committee deems appropriate. (b)Performance Goals. Applicable performance goals shall be established in the discretion of the Committee and may include, but need not be limited to: earnings or earnings growth (including but not limited to earnings per share or net income); economic profit; shareholder value added or economic value added; return on equity, assets or investment; revenues; expenses; stock price or total shareholder return; regulatory compliance; satisfactory internal or external audits; improvement of financial or credit ratings; achievement of asset quality objectives; achievement of balance sheet or income statement objectives, including, without limitation, capital and expense management; efficiency ratio; non-interest income to total revenue ratio; net interest margin; credit quality measures (including non-performing asset ratio, net charge-off ratio, and reserve coverage of nonperforming loans); net operating profit; loan growth; deposit growth; non-interest income growth; market share; productivity ratios; achievement of risk management objectives; strategic goals or objectives (including objectives related to qualitative or quantitative environmental, social or governance metrics); or any other applicable criteria as determined by the Committee. Such performance goals may also be particular to a Participant or the division, department, branch, line of business, subsidiary or other unit in which the Participant works, or may be based on attaining a specified absolute or relative level of the performance goal, or a percentage increase or decrease in the performance goal compared to a pre-established target, previous years’ results, or a designated market index or comparison peer group, all as determined by the Committee. Performance goals need not be uniform among Participants. 13.Deferrals The Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise be due to the Participant in connection with any Grant. The Committee shall establish rules and procedures for any such deferrals, which (a) may provide for interest or other earnings to be paid on such deferrals and (b) shall be consistent with applicable requirements of section 409A of the Code. 14.Withholding of Taxes (a)Required Withholding. All Grants under the Plan shall be subject to applicable federal (including FICA), state and local tax withholding requirements. The Company may require that the Participant or other person receiving or exercising Grants pay to the Company the amount of any federal, state or local taxes that the Company is required to withhold with respect to such Grants, or the Company may deduct from other wages paid by the Company the amount of any withholding taxes due with respect to such Grants, or the Company may take such other action as the Committee may deem advisable to enable the Company to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Grant. (b)Election to Withhold Shares. If the Committee so permits, shares of Company Stock may be withheld to satisfy the Company’s tax withholding obligation with respect to Grants paid in Company Stock, at the time such Grants become taxable, up to an amount that does not exceed the minimum applicable withholding tax rate for federal (including FICA), state and local tax liabilities. The Committee may, in its discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines otherwise, share withholding for taxes shall not exceed the Participant’s minimum applicable tax withholding amount. 15.Transferability of Grants (a)Restrictions on Transfer. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant’s lifetime, and a Participant may not transfer those rights except by will or by the laws of descent and distribution. When a Participant dies, the personal representative or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Grant under the Participant’s will or under the applicable laws of descent and distribution. (b)Transfer of Nonqualified Stock Options to or for Family Members. Notwithstanding the foregoing, the Committee may provide, in a Grant Agreement, that a Participant may transfer Nonqualified Stock Options to family members, or one or more trusts or 80 2024 Proxy Statement other entities for the benefit of or owned by family members, consistent with applicable securities laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer of a Nonqualified Stock Option and the transferred Nonqualified Stock Option shall continue to be subject to the same terms and conditions as were applicable to the Nonqualified Stock Option immediately before the transfer. 16.Consequences of a Change of Control (a)Assumption of Outstanding Awards. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised, unvested or paid at the time of the Change of Control shall be continued, assumed by, or replaced with grants that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change of Control, references to the “Company” as they relate to employment matters shall include the successor employer in the transaction, subject to applicable law. For purposes of the foregoing, a Grant under the Plan shall not be treated as continued, assumed, or replaced on comparable terms unless it is continued, assumed, or replaced with substantially equivalent terms, including, without limitation, the same vesting terms. (b)Vesting Upon Certain Termination Events. Unless otherwise set forth in a Grant Agreement, with respect to Grants, if (i) a Change of Control occurs and (ii) during the period commencing on the date of the Change of Control and ending on the date that is 24 months following the Change of Control, the Participant’s employment or service with the Employer is terminated (1) by the Employer without Cause, (2) by the Participant for Good Reason, (3) by the Employer on account of the Participant’s Disability or (4) on account of the Participant’s death, then all outstanding Options and SARs shall vest and become exercisable and all other outstanding Grants shall vest and all restrictions pertaining to such other Grants shall lapse and have no further effect. For the purposes of this Section 16(b) any Grant that vests based on the attainment of performance goals shall vest assuming that the performance goals were attained at the target level of performance, or at such greater level of performance as the Committee may determine. To the extent Options and SARs vest and become exercisable in accordance with this Section 16(b)they will remain exercisable for 12 months following the termination of the Participant’s employment or service, provided that, in no event shall any Option or SAR be exercisable after the expiration of its term. (c)Other Alternatives. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee may determine that outstanding Options and SARs shall automatically accelerate and become fully exercisable and the restrictions and conditions on outstanding Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine that Participants shall receive a payment in settlement of outstanding Stock Units, Other Stock-Based Awards or Dividend Equivalents, in such amount and form as may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Options and SARs in exchange for a payment by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount, if any, by which the then Fair Market Value of the shares of Company Stock subject to the Participant’s unexercised Options and SARs exceeds the Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all of their outstanding Options and SARs, the Committee may terminate any or all unexercised Options and SARs at such time as the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Company Stock does not exceed the per share Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any payment to the Participant upon surrender of the Option or SAR. 17.Requirements for Issuance of Shares No Company Stock shall be issued in connection with any Grant hereunder unless and until all legal requirements applicable to the issuance of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have the right to condition any Grant made to any Participant hereunder on such Participant’s undertaking in writing to comply with such restrictions on his or her subsequent disposition of such shares of Company Stock as the Committee shall deem necessary or advisable, and certificates, or electronic book entry equivalents, representing such shares may be legended to reflect any such restrictions. Certificates, or electronic book entry equivalents, representing shares of Company Stock issued under the Plan may be subject to such stop-transfer orders and other restrictions as may be required by applicable laws, regulations and interpretations, including any 2024 Proxy Statement 81 requirement that a legend be placed thereon. No Participant shall have any right as a shareholder with respect to Company Stock covered by a Grant until shares have been issued to the Participant. 18.Amendment and Termination of the Plan (a)Amendment. The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without approval of the shareholders of the Company if such approval is required in order to comply with the Code or applicable laws, or to comply with applicable stock exchange requirements. Notwithstanding anything in the Plan to the contrary, the Board may amend the Plan in such manner as it deems appropriate in the event of a change in applicable law or regulations. (b)No Repricing Without Shareholder Approval. Notwithstanding anything in the Plan to the contrary, except in connection with a corporate transaction involving the Company (including, without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, or exchange of shares), the terms of outstanding Grants may not be amended to reduce the Exercise Price of outstanding Options or exercise price or base amount of SARs or cancel outstanding Options or SARs in exchange for cash, other Grants of Options or SARs with an Exercise Price or base amount that is less than the Exercise Price or base amount of the original Options or SARs without shareholder approval. (c)Termination of Plan. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is terminated earlier by the Board or is extended by the Board with the approval of the shareholders. The termination of the Plan shall not impair Grants outstanding or the power and authority of the Committee with respect to an outstanding Grant. (d)Termination and Amendment of Outstanding Grants. A termination or amendment of the Plan that occurs after a Grant is made shall not materially impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under Section 19(c) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant. Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under Section 19(c) below or may be amended by agreement of the Company and the Participant consistent with the Plan. 19.Miscellaneous (a)Effective Date. The Plan shall be effective as of the Effective Date, if approved by the Company’s shareholders on such date. (b)Grants in Connection with Corporate Transactions and Otherwise. Nothing contained in this Plan shall be construed to (i) limit the right of the Committee to make Grants under this Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or for other proper corporate purposes, or (ii) limit the right of the Company to grant stock options or make other stock-based awards outside of this Plan. Without limiting the foregoing, the Committee may make a Grant to an employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or liquidation involving the Company in substitution for a grant made by such corporation. The terms and conditions of the Grants may vary from the terms and conditions required by the Plan and from those of the substituted stock incentives, as determined by the Committee. (c)Compliance with Law. (i)The Plan, the exercise of Options and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall be subject to all applicable laws and to approvals by any governmental or regulatory agency as may be required. With respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code. To the extent that any legal requirement of section 16 of the Exchange Act or section 422 as set forth in the Plan ceases to be required under section 16 of the Exchange Act or section 422 of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority under this Section. (ii)The Plan is intended to comply with the requirements of section 409A of the Code, to the extent applicable. Each Grant shall be construed and administered such that the Grant either (A) qualifies for an exemption from the requirements of 82 2024 Proxy Statement section 409A of the Code or (B) satisfies the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (I) distributions shall only be made in a manner and upon an event permitted under section 409A of the Code, (II) payments to be made upon a termination of employment shall only be made upon a “separation from service” under section 409A of the Code, (III) unless the Grant specifies otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (IV) in no event shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section 409A of the Code. (iii)Any Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the date of the Participant’s separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant’s death. The determination of “Key Employees”, including the number and identity of persons considered Key Employees and the identification date, shall be made by the Committee or its delegate each year in accordance with section 416(i) of the Code and the “specified employee” requirements of section 409A of the Code. (iv)Notwithstanding anything in the Plan or any Grant Agreement to the contrary, each Participant shall be solely responsible for the tax consequences of Grants under the Plan, and in no event shall the Company have any responsibility or liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to administer the Plan to prevent taxation under section 409A of the Code, the Company does not represent or warrant that the Plan or any Grant complies with any provision of federal, state, local or other tax law. (d)Enforceability. The Plan shall be binding upon and enforceable against the Company and its successors and assigns. (e)Funding of the Plan; Limitation on Rights. This Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any other segregation of assets to assure the payment of any Grants under this Plan. Nothing contained in the Plan and no action taken pursuant hereto shall create or be construed to create a fiduciary relationship between the Company and any Participant or any other person. No Participant or any other person shall under any circumstances acquire any property interest in any specific assets of the Company. To the extent that any person acquires a right to receive payment from the Company hereunder, such right shall be no greater than the right of any unsecured general creditor of the Company. (f)Rights of Participants. Nothing in this Plan shall entitle any Employee, Non-Employee Director, Consultant or other person to any claim or right to receive a Grant under this Plan. Neither this Plan nor any action taken hereunder shall be construed as giving any individual any rights to be retained by or in the employment or service of the Employer. (g)No Fractional Shares. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. The Committee shall determine whether cash, other awards or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated. (h)Employees Subject to Taxation outside the United States. With respect to Participants who are subject to taxation in countries other than the United States, the Committee may make Grants on such terms and conditions as the Committee deems appropriate to comply with the laws of the applicable countries, and the Committee may create such procedures, addenda and subplans and make such modifications as may be necessary or advisable to comply with such laws. (i)Company Policies; Clawback Rights. All Grants under the Plan shall be subject to any applicable share trading policies and other policies that may be approved or implemented by the Board or the Committee from time to time, whether or not approved before or after the Effective Date. All Grants and amounts payable under the Plan are additionally subject to the terms of any applicable clawback policies approved by the Board or Committee, as in effect from time to time (including, without limitation, a clawback policy required to be implemented by an applicable stock exchange), whether approved before or after the date of grant of a Grant (as applicable, a “Clawback Policy”). Further, to the extent permitted by applicable law, including without limitation Section 409A of the Code, all amounts payable under the Plan are subject to offset in the event that a Participant has an outstanding clawback, recoupment or forfeiture obligation to the Company under the terms of any applicable Clawback Policy. In the event of a clawback, recoupment or forfeiture event under an applicable Clawback Policy, the amount required to be clawed back, recouped or forfeited pursuant to such policy shall be deemed not to have been earned under the terms of the Plan, and the Company shall be entitled to recover from the Participant the amount specified under the Clawback Policy to be clawed back, recouped or forfeited (which amount, as applicable, shall be deemed an advance that remained subject to the Participant satisfying all eligibility conditions for earning the amounts deferred, accrued, or credited under this Plan). 2024 Proxy Statement 83 (j)Governing Law. The validity, construction, interpretation and effect of the Plan and Grant Agreements issued under the Plan shall be governed and construed by and determined in accordance with the laws of the Commonwealth of Pennsylvania, without giving effect to the conflict of laws provisions thereof. 84 2024 Proxy Statement
|